NHS Stock Recent News

Britain could face higher drug costs as part of a deal to stave off future tariffs from Donald Trump, according to a report in the Daily Telegraph. Documents released after a recent trade agreement show the NHS is expected to review its approach to drug pricing in response to US demands.

NEW YORK , May 30, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on June 30, 2025, has a record date of June 16, 2025, and has an ex-date of June 16, 2025.

NHS provides a high 14.7% yield by investing in below investment grade debt, but this comes with elevated risk and price volatility. The fund's NAV and price have steadily declined, reflecting sensitivity to high interest rates and aggressive leverage use. Dividend sustainability is questionable, as earnings often fail to cover distributions, risking further NAV erosion if payouts aren't reduced.

LONDON--(BUSINESS WIRE)--AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced that its Phase 1/2 ASPIRE-FTD clinical trial is now open in the UK. The trial is evaluating AVB-101, an investigational gene therapy, in people with frontotemporal dementia (FTD) with GRN gene mutations (FTD-GRN). Cambridge University Hospitals NHS Foundation Trust (CUH), which hosts an internationally.

NEW YORK , April 30, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on May 30, 2025, has a record date of May 15, 2025, and has an ex-date of May 15, 2025.

Heightened market volatility offers unique buying opportunities for income investors, particularly in high-yield income funds like CEFs and ETFs, ideal for retirement portfolios. CEFs are attractive due to their potential to trade at a discount, leverage to magnify returns, and managed distribution policies, despite the misunderstood concept of return of capital. Four recommended CEFs—OPP, CCIF, NHS, and ECAT—offer high yields and are suited for different economic scenarios, providing diverse options for income compounder portfolios.

NEW YORK , March 31, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on April 30, 2025, has a record date of April 15, 2025, and has an ex-date of April 15, 2025.

The Neuberger Berman High Yield Strategies Fund offers a 14.23% yield, significantly higher than major bond indices and its peers, raising concerns about sustainability. The NHS closed-end fund's high yield may indicate market skepticism about its ability to maintain distributions, necessitating a closer look at its finances. The fund appears to be increasing its exposure to fixed-rate securities, which is likely the correct move as the Federal Reserve reduces interest rates.

NEW YORK , March 3, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on March 31, 2025, has a record date of March 17, 2025, and has an ex-date of March 17, 2025.

NEW YORK , Jan. 31, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on February 28, 2025, has a record date of February 18, 2025, and has an ex-date of February 18, 2025.